Overall slowdown in the economy and growing volumes of unbranded generic medicines in the domestic market are behind poor sales.
Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain their affordability.
The Pradhan Mantri Jan Aushadhi Yojana or PMJAY has not been a runaway success by any yardstick. Not all stores are running, and many are poorly stocked.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances